ArQule, Inc.
(NASDAQ:ARQL)|
3.35 +0.04 (1.21%) Dec 04 - Close |
|
|
|
After-Hours 3.37 +0.02 (0.60%) Thu, 4 Dec 2008 7:40 PM
- Compare ARQL with:
- View: Line | Candlestick
Company Profile
ArQule, Inc.
19 Presidential Way
Woburn, MA 01801
United States - Map
Phone: (781) 994-0300
Fax: (781) 376-6019
Website: www.arqule.com
State of incorporation: Delaware
CEO: Paolo Pucci
Employees: 113
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Disc/produce novel chemical compounds
A clinical-stage biotechnology company, which is engaged in the research and development of cancer therapeutics.
Recent news for ARQL
-
Navigating the Micro-Cap Biotech Minefield
Seeking Alpha - Nov 23 at 10:26 ET
-
EDGAR Online Financials - Nov 15 at 9:04 ET
-
ArQule, Inc. to Present at Lazard Capital Markets Healthcare Conference
Business Wire - Nov 14 at 8:15 ET
-
Zacks #1 Rank Additions for Wednesday
Zacks.com - Nov 12 at 7:24 ET
-
ArQule Joins Forces with Daiichi Sankyo to Fight Cancer
Seeking Alpha - Nov 11 at 11:13 ET
-
New Star Analyst Rankings for ArQule, Inc.
StarMine - Nov 11 at 9:24 ET
-
ArQule, Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha - Nov 10 at 4:11 ET
-
EDGAR Online - Nov 10 at 2:00 ET
-
ArQule, Inc. Earnings Call scheduled for 9:00 am ET today
CCBN - Nov 10 at 9:00 ET
-
UPDATE - ArQule and Japan's Daiichi to develop cancer drugs
Reuters - Nov 10 at 8:39 ET